Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 1998

Detection of specific IgM-CLASS antitreponemal antibodies in blood serum of patients with syphilis with the use of CAPTIA Syphilis-M reaction and comparing it with VDRL, FTA-ABS and TPHA reactions

Mieczysław Gibowski, Ryszard Żaba, Tatiana Machońko

Med Sci Monit 1998; 4(5): PI882-888 :: ID: 502060


The aim of the study was to observe specific IgM-class antitreponemal antibodies in blood serum of patients with syphilis, with the use of immunoenzyme reaction CAPTIA Syphilis-M and to compare it with other routine syphilis serological reactions (VDRL, FTA-ABS and TPHA). The authors investigated the serum of the total of 200 patients with syphilis (123 men and 77 women), including 110 patients with early syphilis (not treated so far) and 90 patients with late syphilis (14 not treated subjects and 76 treated subjects). The patients were divided into subgroups depending on syphilis type. Examinations were performed with immunoenzyme reaction CAPTIA Syphilis-M and its results were compared with those obtained with the use of VDRL, FTA-ABS and TPHA reactions. Positive CAPTIA Syphilis-M results were observed in 90% of patients with early syphilis, and in only 11% of patients with late syphilis. As far as primary syphilis is concerned, this reaction was positive in 100% of subjects, while VDRL - in 56%, and TPHA and FTA-ABS - in 67% of cases. A slightly earlier negativity of CAPTIA Syphilis-M reaction when compared with VDRL was observed after therapy with penicillin. The authors presume that CAPTIA Syphilis-M is particularly useful in the diagnostics of early syphilis (especially primary syphilis) and that it is a more sensitive index of treatment efficiency than VDRL reaction.

Keywords: syphilis, serological reactions, CAPTIA Syphilis-M reaction

Add Comment 0 Comments


01 July 2024 : Editorial  

Editorial: The Global Threats of Increasing Antimicrobial Resistance Require New Approaches to Drug Development, Including Molecular Antimicrobial Adjuvants

Dinah V. Parums

DOI: 10.12659/MSM.945583

Med Sci Monit 2024; 30:e945583


In Press

Database Analysis  

Enhanced Outcomes in Femoral Subtrochanteric Fractures Using Long INTERTAN Nails with Titanium Cable Cercla...

Med Sci Monit In Press; DOI: 10.12659/MSM.944383  


Database Analysis  

Trends in HIV/AIDS-Related Mortality and the Impact of Antiretroviral Treatment Strategies in Lu'an City: A...

Med Sci Monit In Press; DOI: 10.12659/MSM.944727  

Review article  

Optimizing Quality of Life in Kidney Transplant Recipients Through Structured Exercise: A Systematic Review...

Med Sci Monit In Press; DOI: 10.12659/MSM.943617  

Clinical Research  

Ultrasound-Guided PRP and SVF Therapy Shows Sustained Improvement in Severe Knee Osteoarthritis: A 12-Month...

Med Sci Monit In Press; DOI: 10.12659/MSM.943975  

Most Viewed Current Articles

17 Jan 2024 : Review article   4,290,652

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research   1,595,389

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research   691,055

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial   50,864

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750